The Worldwide Chronic Kidney Disease Market is expected to grow at a CAGR of 5.2% during the forecast period 2017 to 2023. The chronic kidney disease is characterized by the gradual loss of kidney function over the period. If left untreated, it may lead to kidney failure. Type 1 or Type 2 diabetes, high blood pressure, glomerulonephritis, interstitial nephritis, polycystic kidney disease, and others are the common indications for the chronic kidney disease.
The disease can be treated through administration of drugs at the early stage and dialysis and kidney transplant at the last stage. Key drivers for the growth of the market are increasing the prevalence of kidney diseases, increasing number of biopsy procedures, and the rising demand for new techniques for diagnosis of chronic diseases. Moreover, the availability of various diagnostic tests for kidney diseases also influences the growth of the market. The increasing number of market players is also expected to stimulate the growth of the market during the forecast period.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/5744 .
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) stated that the kidney disease is frequently referred to as a “silent disease” as there are no symptoms in its early stages and can go undetected. The disease is a global health burden risk factor for Cardiovascular Diseases (CVDs). It also stated that the overall prevalence of chronic kidney disease in the general population is nearly 14%.
Chronic Kidney Disease Market Segmentations:
The Global Chronic Kidney Disease Market is segmented on the basis of diagnosis, treatment, indication, and end-user. On the basis of diagnosis, it is segmented into blood test, urine test, imaging test, and kidney biopsy.
On the basis of treatment, it is segmented into drugs, dialysis, and kidney transplant. Drugs are further segmented into ace inhibitors, angiotensin-ii receptor blockers, calcium channel blockers, beta-blockers, and erythropoiesis-stimulating agents.
On the basis of indication, it is segmented into Type 1 or Type 2 diabetes, high blood pressure, polycystic kidney disease, and others. On the basis of end-user, it is segmented into hospitals and clinics, diagnostic centers, and others.
Global Chronic Kidney Disease Market Regional Analysis:
The American chronic kidney disease market is driven by the increasing population with kidney diseases, extensive use of diagnostic tests for detecting kidney failure, and the increasing demand for new treatment options for kidney diseases.
In Europe, the market is driven by the growth of the medical device industry and the increasing awareness about risk factors for kidney diseases. Additionally, the increasing diabetic population and huge investments in the medical device sector by major market players also fuel the growth of the market. Germany, the largest market for chronic kidney diseases, is driven by the increasing emphasis on the development of new drugs, rising government support for research and development, and availability of funds for research.
Asia Pacific is the fastest growing chronic kidney disease market owing to the increasing prevalent diseases such as diabetes and cardiovascular diseases. Improving hospital infrastructure, the presence of skilled healthcare professionals, and rapid development in the healthcare technology are also expected to accelerate the growth of the market during the forecast period.
The Middle East and Africa hold the least share of the chronic kidney disease market due to limitations to technology and unawareness about kidney diseases and their treatments.
Chronic Kidney Disease Market Key Players:
Abbott, Siemens, Sysmex, Beckman Coulter, F. Hoffmann-La Roche Ltd, ACON Laboratories, Inc., URIT Medical, Nova Biomedical, ARKRAY, OPTI Medical, 77 Elektronika, Randox Laboratories, Teva Pharmaceutical Industries Ltd., Amgen Inc., AstraZeneca Plc, Pfizer Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., GlaxoSmithKline Plc, AbbVie Inc., and Kissei Pharmaceutical Co. Ltd.
Get Discount @ https://www.marketresearchfuture.com/sample_request/5744 .
Some of Major TOC Global Chronic Kidney Disease Market Research Report- Forecast to 2023:
1 History and Evolution of Chronic Kidney Disease
1.1 Scenario Analysis
2 Report Prologue
3.1 Scope of Study
3.2 Research Objective
3.3 Assumptions & Limitations
3.4 Market Structure
4 Research Methodology
4.1 Market Size Estimation
4.1.1 Market Share analysis
4.2 Market Pricing Approach
Any Questions to Expertise @ https://www.marketresearchfuture.com/sample_request/5744 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312